Who
Kathryn Jean Boor
Director
Company insider
Files Form 4 as: Director, Sarepta Therapeutics; Director, International Flavors & Fragrances.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $299K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Mar 2021
- Last trade
- 4 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 5 Jun 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —16,875 | filing |
| 4 Jun 2026filed 5 Jun 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —16,875 | filing |
| 1 May 2025filed 5 May 2025 | IFF International Flavors & Fragrancesoption or derivative · Chemicals | SEC FORM 4 Code A | —2,569 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,792 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,383 | filing |
| 5 Dec 2024filed 6 Dec 2024 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Sold | $205K1,636 at $125.55 | filing |
| 1 May 2024filed 3 May 2024 | IFF International Flavors & Fragrancesoption or derivative · Chemicals | SEC FORM 4 Code A | —1,875 at $0.00 | filing |
| 11 Mar 2024filed 11 Mar 2024 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Sold | $94K761 at $122.93 | filing |
| 1 Mar 2024filed 5 Mar 2024 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,679 at $0.00 | filing |
| 1 Mar 2024filed 5 Mar 2024 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —1,846 at $0.00 | filing |
| 4 May 2023filed 5 May 2023 | IFF International Flavors & Fragrancesoption or derivative · Chemicals | SEC FORM 4 Code D | —1,245 at $0.00 | filing |
| 4 May 2023filed 5 May 2023 | IFF International Flavors & Fragrancesoption or derivative · Chemicals | SEC FORM 4 Code A | —1,245 at $0.00 | filing |
| 6 Mar 2023filed 8 Mar 2023 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,257 at $0.00 | filing |
| 6 Mar 2023filed 8 Mar 2023 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —1,523 at $0.00 | filing |
| 2 Jun 2022filed 6 Jun 2022 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,329 at $0.00 | filing |
| 2 Jun 2022filed 6 Jun 2022 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,908 at $0.00 | filing |
| 5 May 2022filed 6 May 2022 | IFF International Flavors & Fragrancesoption or derivative · Chemicals | SEC FORM 4 Code D | —1,089 at $0.00 | filing |
| 5 May 2022filed 6 May 2022 | IFF International Flavors & Fragrancesoption or derivative · Chemicals | SEC FORM 4 Code A | —1,089 at $0.00 | filing |
| 4 May 2022filed 6 May 2022 | IFF International Flavors & Fragrancesoption or derivative · Chemicals | SEC FORM 4 Code A | —1,245 at $0.00 | filing |
| 6 May 2021filed 7 May 2021 | IFF International Flavors & Fragrancesoption or derivative · Chemicals | SEC FORM 4 Code M | —255 at $0.00 | filing |
News
Comparing Sarepta Therapeutics (NASDAQ:SRPT) and Protagonist Therapeutics (NASDAQ:PTGX)SRPT · dailypolitical.com · 22 Oct 2026Contrasting Sarepta Therapeutics (NASDAQ:SRPT) & AbCellera Biologics (NASDAQ:ABCL)SRPT · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Kathryn Jean Boor; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.